Clinical trial
Randomized Comparison of Tissue Quality and Molecular Yield Between a Novel Crown-cut Biopsy Needle (FNB) and a Standard Aspiration Needle (FNA) for EUS Guided Diagnosis of Solid Pancreatic Lesions
NCT04687410 is registered in ClinicalTrials.gov with Peter Vilmann MD, DSc, HC, FASGE as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Comparison of Tissue Quality and Molecular Yield Between a Novel Crown-cut Biopsy Needle (FNB) and a Standard Aspiration Needle (FNA) for EUS Guided Diagnosis of Solid Pancreatic Lesions
- Lead sponsor
- Peter Vilmann MD, DSc, HC, FASGE
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 15, 2020
- Completion date
- June 1, 2021
- Enrollment
- 68 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreas cancer, pancreas neoplasm